EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Mechanistic Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach Informed by In Vitro and Clinical Studies for Topical Administration of Adapalene Gels

Namrata S Matharoo iD, Harsha T Garimella iD, Thu M Truong iD, Saiaditya Badeti iD, Joyce X Cui, Sesha Rajeswari Talluri, Amitkumar Virani, Babar K Rao, Bozena Michniak-Kohn

Pharmaceutics · 25.08.2025 · 17 (9) · 1108

DOI: 10.3390/pharmaceutics17091108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 25.08.2025. Verfasst von Namrata S Matharoo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Dermal Research, Rutgers, The State University of New Jersey, 145 Bevier Road, Piscataway, NJ 08854, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FDA HHS, National Institutes of Health/U.S. Food and Administration under the Small Business Innovation Research (SBIR) grants, National Institutes of Health/U.S. Food and Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Adapalene is a synthetic retinoid used as a treatment for acne vulgaris. In this study, we attempted to evaluate the dermal pharmacokinetics of adapalene utilizing experimental and in silico tools.

Methods

We utilized three over the counter (OTC) adapalene gels to evaluate local dermal pharmacokinetics. A data-driven, robust, mechanistic dermal physiologically based pharmacokinetic (PBPK) model was developed by integrating the physicochemical properties of adapalene, the formulation attributes of the gels, and the biophysical aspects of dermal absorption. The dermal PBPK model was validated against experimental data using in vitro release studies and in vitro permeation studies with human cadaver skin. A clinical study was performed to evaluate the effects of adapalene from the three gel formulations. The impact of adapalene delivery from three gels on the stratum corneum (SC) thickness, pilosebaceous unit area, keratinocyte number, and epidermal thickness was captured using a non-invasive technique, line-field confocal optical coherence tomography (LC–OCT). These responses were evaluated using an Emax model.

Results

The dermal PBPK model has successfully predicted adapalene penetration profiles across different gel formulations. The model accuracy, in predicting drug release and permeation characteristics, was confirmed using the experimental data. Clinical evaluation revealed formulation-dependent differences in adapalene’s effects on measured skin parameters, with distinct pharmacodynamic profiles observed for each gel formulation.

Conclusions

The overall study gave us a detailed insight into potential effects of formulation on the dermal pharmacokinetics and pharmacodynamics of adapalene using three marketed gels.

Schlagwörter

Stichwörter der Autor:innen

acne vulgarisadapalenebioequivalenceclinical studiesgelspermeation testingpharmacokinetic pharmacodynamic modelingphysiologically based pharmacokinetic modelingrelease testingretinoidstopical delivery

Autor:innen und Institutionen

  • Center for Dermal Research, Rutgers, The State University of New Jersey, 145 Bevier Road, Piscataway, NJ 08854, USA.
  • Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Rd, Piscataway, NJ 08854, USA.
  • CFD Research Corporation, 6820 Moquin Dr NW, Huntsville, AL 35806, USA.
  • Montefiore Medical Center, Division of Dermatology, Bronx, NY 10461, USA.
  • Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.

ORCID-Profile: Namrata S Matharoo, Harsha T Garimella, Thu M Truong, Saiaditya Badeti

Förderung

  • FDA HHS
  • National Institutes of Health/U.S. Food and Administration under the Small Business Innovation Research (SBIR) grants
  • National Institutes of Health/U.S. Food and Administration
  • Center for Dermal Research, Rutgers-The State University of New Jersey

Zitieren

APA

Matharoo, N. S., Garimella, H. T., Truong, T. M., Badeti, S., Cui, J. X., Talluri, S. R., Virani, A., Rao, B. K., & Michniak-Kohn, B. (2025). A Mechanistic Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach Informed by In Vitro and Clinical Studies for Topical Administration of Adapalene Gels. Pharmaceutics, 17(9), 1108. https://doi.org/10.3390/pharmaceutics17091108

Vancouver

Matharoo NS, Garimella HT, Truong TM, Badeti S, Cui JX, Talluri SR, et al. A Mechanistic Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach Informed by In Vitro and Clinical Studies for Topical Administration of Adapalene Gels. Pharmaceutics. 2025;17(9):1108. doi:10.3390/pharmaceutics17091108

BibTeX
@article{Matharoo2025,
  author = {Matharoo, Namrata S and Garimella, Harsha T and Truong, Thu M and Badeti, Saiaditya and Cui, Joyce X and Talluri, Sesha Rajeswari and Virani, Amitkumar and Rao, Babar K and Michniak-Kohn, Bozena},
  title = {A Mechanistic Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach Informed by In Vitro and Clinical Studies for Topical Administration of Adapalene Gels},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1108},
  doi = {10.3390/pharmaceutics17091108}
}
Kostenlos starten →